The DAIDS Safety and Pharmacovigilance Team (SPT) is a Team at DAIDS within OPCRO that is responsible for safety and pharmacovigilance activities related to clinical trials sponsored/funded by DAIDS.
The DAIDS RSC Safety Office works closely with DAIDS SPT and provides support by collecting adverse events reported by sites participating in DAIDS-supported studies, processing the events for review by the DAIDS Medical Officer, and preparing the reports for transmittal to the Food and Drug Administration (FDA), if required. They also support DAIDS SPT in establishing internal procedures and developing Safety training for the Clinical Research Sites.
Content last reviewed on